The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drugs of Abuse Testing Market Research Report 2024

Global Drugs of Abuse Testing Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1805353

No of Pages : 81

Global Drugs of Abuse Testing market is projected to reach US$ 3956.6 million in 2029, increasing from US$ 2874.4 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drugs of Abuse Testing market research.

Key companies engaged in the Drugs of Abuse Testing industry include Quest Diagnostics, F. Hoffmann La-Roche, Siemens, Thermo Fisher Scientific, Abbott, Shimadzu and Laboratory Corporation of America, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Drugs of Abuse Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Drugs of Abuse Testing market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Drugs of Abuse Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Quest Diagnostics
  •     F. Hoffmann La-Roche
  •     Siemens
  •     Thermo Fisher Scientific
  •     Abbott
  •     Shimadzu
  •     Laboratory Corporation of America

Segment by Type

  •     Psychostimulants
  •     Narcotic
  •     Hallucinogens
  •     Sedatives
  •     Others

Segment by Application

  •     Hospitals
  •     Diagnostics Laboratories
  •     Forensic Laboratories
  •     Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Drugs of Abuse Testing report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drugs of Abuse Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Psychostimulants
        1.2.3 Narcotic
        1.2.4 Hallucinogens
        1.2.5 Sedatives
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Drugs of Abuse Testing Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Diagnostics Laboratories
        1.3.4 Forensic Laboratories
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Drugs of Abuse Testing Market Perspective (2018-2029)
    2.2 Drugs of Abuse Testing Growth Trends by Region
        2.2.1 Global Drugs of Abuse Testing Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Drugs of Abuse Testing Historic Market Size by Region (2018-2023)
        2.2.3 Drugs of Abuse Testing Forecasted Market Size by Region (2024-2029)
    2.3 Drugs of Abuse Testing Market Dynamics
        2.3.1 Drugs of Abuse Testing Industry Trends
        2.3.2 Drugs of Abuse Testing Market Drivers
        2.3.3 Drugs of Abuse Testing Market Challenges
        2.3.4 Drugs of Abuse Testing Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Drugs of Abuse Testing Players by Revenue
        3.1.1 Global Top Drugs of Abuse Testing Players by Revenue (2018-2023)
        3.1.2 Global Drugs of Abuse Testing Revenue Market Share by Players (2018-2023)
    3.2 Global Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Drugs of Abuse Testing Revenue
    3.4 Global Drugs of Abuse Testing Market Concentration Ratio
        3.4.1 Global Drugs of Abuse Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drugs of Abuse Testing Revenue in 2022
    3.5 Drugs of Abuse Testing Key Players Head office and Area Served
    3.6 Key Players Drugs of Abuse Testing Product Solution and Service
    3.7 Date of Enter into Drugs of Abuse Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Drugs of Abuse Testing Breakdown Data by Type
    4.1 Global Drugs of Abuse Testing Historic Market Size by Type (2018-2023)
    4.2 Global Drugs of Abuse Testing Forecasted Market Size by Type (2024-2029)

 5 Drugs of Abuse Testing Breakdown Data by Application
    5.1 Global Drugs of Abuse Testing Historic Market Size by Application (2018-2023)
    5.2 Global Drugs of Abuse Testing Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Drugs of Abuse Testing Market Size (2018-2029)
    6.2 North America Drugs of Abuse Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Drugs of Abuse Testing Market Size by Country (2018-2023)
    6.4 North America Drugs of Abuse Testing Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Drugs of Abuse Testing Market Size (2018-2029)
    7.2 Europe Drugs of Abuse Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Drugs of Abuse Testing Market Size by Country (2018-2023)
    7.4 Europe Drugs of Abuse Testing Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Drugs of Abuse Testing Market Size (2018-2029)
    8.2 Asia-Pacific Drugs of Abuse Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Drugs of Abuse Testing Market Size by Region (2018-2023)
    8.4 Asia-Pacific Drugs of Abuse Testing Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Drugs of Abuse Testing Market Size (2018-2029)
    9.2 Latin America Drugs of Abuse Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Drugs of Abuse Testing Market Size by Country (2018-2023)
    9.4 Latin America Drugs of Abuse Testing Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Drugs of Abuse Testing Market Size (2018-2029)
    10.2 Middle East & Africa Drugs of Abuse Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Drugs of Abuse Testing Market Size by Country (2018-2023)
    10.4 Middle East & Africa Drugs of Abuse Testing Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Quest Diagnostics
        11.1.1 Quest Diagnostics Company Detail
        11.1.2 Quest Diagnostics Business Overview
        11.1.3 Quest Diagnostics Drugs of Abuse Testing Introduction
        11.1.4 Quest Diagnostics Revenue in Drugs of Abuse Testing Business (2018-2023)
        11.1.5 Quest Diagnostics Recent Development
    11.2 F. Hoffmann La-Roche
        11.2.1 F. Hoffmann La-Roche Company Detail
        11.2.2 F. Hoffmann La-Roche Business Overview
        11.2.3 F. Hoffmann La-Roche Drugs of Abuse Testing Introduction
        11.2.4 F. Hoffmann La-Roche Revenue in Drugs of Abuse Testing Business (2018-2023)
        11.2.5 F. Hoffmann La-Roche Recent Development
    11.3 Siemens
        11.3.1 Siemens Company Detail
        11.3.2 Siemens Business Overview
        11.3.3 Siemens Drugs of Abuse Testing Introduction
        11.3.4 Siemens Revenue in Drugs of Abuse Testing Business (2018-2023)
        11.3.5 Siemens Recent Development
    11.4 Thermo Fisher Scientific
        11.4.1 Thermo Fisher Scientific Company Detail
        11.4.2 Thermo Fisher Scientific Business Overview
        11.4.3 Thermo Fisher Scientific Drugs of Abuse Testing Introduction
        11.4.4 Thermo Fisher Scientific Revenue in Drugs of Abuse Testing Business (2018-2023)
        11.4.5 Thermo Fisher Scientific Recent Development
    11.5 Abbott
        11.5.1 Abbott Company Detail
        11.5.2 Abbott Business Overview
        11.5.3 Abbott Drugs of Abuse Testing Introduction
        11.5.4 Abbott Revenue in Drugs of Abuse Testing Business (2018-2023)
        11.5.5 Abbott Recent Development
    11.6 Shimadzu
        11.6.1 Shimadzu Company Detail
        11.6.2 Shimadzu Business Overview
        11.6.3 Shimadzu Drugs of Abuse Testing Introduction
        11.6.4 Shimadzu Revenue in Drugs of Abuse Testing Business (2018-2023)
        11.6.5 Shimadzu Recent Development
    11.7 Laboratory Corporation of America
        11.7.1 Laboratory Corporation of America Company Detail
        11.7.2 Laboratory Corporation of America Business Overview
        11.7.3 Laboratory Corporation of America Drugs of Abuse Testing Introduction
        11.7.4 Laboratory Corporation of America Revenue in Drugs of Abuse Testing Business (2018-2023)
        11.7.5 Laboratory Corporation of America Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’